Cline Scientific
Cline Scientific provides an update on the company's financial position
The board has continued to work to find solutions to strengthen the company's financial position in both the short and long term. This work has not yet yielded any results and no decision regarding the company's appeal against the rejection to its application in the EIC accelerator has been received. The board continues this work with undiminished vigour.
Currently, the company's working capital is estimated to last through August 2024.
The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser.
This information is information that Cline Scientific is required to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication by the contact person set out above, at 10:05 am CEST on 30 April 2024.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 0703585088
| Datum | 2024-04-30, kl 10:05 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!